bioAffinity Technologies, Inc. (BIAF)

NASDAQ: BIAF · Real-Time Price · USD

1.260

-0.060 (-4.55%)

At close: Jan 28, 2026, 4:00 PM EST

1.240

-0.020 (-1.59%)

Pre-market: Jan 29, 2026, 9:09 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Laboratory Services	9.35M	Log In	Log In
Laboratory Services Growth	272.19%	Log In	Log In
Diagnostic Research and Development	8.65K	Log In	Log In
Diagnostic Research and Development Growth	-55.49%	Log In	Log In
CyPath Lung Flow Cytometry Test	-	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
United States	9.36M	Log In	Log In
United States Growth	269.68%	Log In	Log In